We are currently working to resolve technical issues preventing us from processing applications or payment for membership. Please email Membership on subscriptions@rheumatology.org.uk with any queries.
Search

Overview

Hydroxychloroquine: efficacy, dosing and retinopathy
Date
30 September, 19:00
CPD
1 hour
Audience: entire multidisciplinary team
Speakers: Prof Chris Edwards, Southampton University Hospital, Dr James Galloway, Kings College Hospital

Overview

Giving you the latest information around hydroxychloroquine (HCQ) efficacy, dosing and retinopathy so you can make confident and appropriate prescribing decisions around this important agent in both rheumatoid arthritis (RA) and lupus (SLE).

Topics include:
  • An overview of HCQ efficacy in rheumatoid arthritis and lupus
  • HCQ retinopathy – what is it?
  • Practical steps for the clinic

Learning objectives

  1. Understand the latest clinical data relating to HCQ efficacy in SLE and RA
  2. Gain a deeper knowledge of HCQ retinopathy and monitoring guidelines
  3. Learn to balance benefit and risk of HCQ weight-based dosing

Register

To register for our exclusive webinars, simply log in with your membership details. Not yet a member? Sign up today to gain access.

Join now